DK163030C - Laegemidler, der er emballeret med henblik paa administration ved injektion - Google Patents

Laegemidler, der er emballeret med henblik paa administration ved injektion

Info

Publication number
DK163030C
DK163030C DK554585A DK554585A DK163030C DK 163030 C DK163030 C DK 163030C DK 554585 A DK554585 A DK 554585A DK 554585 A DK554585 A DK 554585A DK 163030 C DK163030 C DK 163030C
Authority
DK
Denmark
Prior art keywords
medicinal products
injection administration
products packaged
injection
combination
Prior art date
Application number
DK554585A
Other languages
English (en)
Other versions
DK163030B (da
DK554585A (da
DK554585D0 (da
Inventor
Pierre Casellas
Bernard Bourrie
Pierre Gros
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK554585D0 publication Critical patent/DK554585D0/da
Publication of DK554585A publication Critical patent/DK554585A/da
Publication of DK163030B publication Critical patent/DK163030B/da
Application granted granted Critical
Publication of DK163030C publication Critical patent/DK163030C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK554585A 1984-11-29 1985-11-29 Laegemidler, der er emballeret med henblik paa administration ved injektion DK163030C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8418203 1984-11-29
FR8418203A FR2573656B1 (fr) 1984-11-29 1984-11-29 Medicament comportant en tant qu'association au moins une immunotoxine et au moins un polymere contenant du mannose

Publications (4)

Publication Number Publication Date
DK554585D0 DK554585D0 (da) 1985-11-29
DK554585A DK554585A (da) 1986-05-30
DK163030B DK163030B (da) 1992-01-13
DK163030C true DK163030C (da) 1992-06-15

Family

ID=9310066

Family Applications (1)

Application Number Title Priority Date Filing Date
DK554585A DK163030C (da) 1984-11-29 1985-11-29 Laegemidler, der er emballeret med henblik paa administration ved injektion

Country Status (13)

Country Link
US (1) US4749566A (da)
EP (1) EP0186551B1 (da)
JP (1) JPH062679B2 (da)
AT (1) ATE49708T1 (da)
AU (1) AU588008B2 (da)
CA (1) CA1254139A (da)
DE (1) DE3575521D1 (da)
DK (1) DK163030C (da)
FR (1) FR2573656B1 (da)
IE (1) IE58776B1 (da)
IL (1) IL77168A0 (da)
NZ (1) NZ214357A (da)
ZA (1) ZA859120B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185434A (en) * 1985-02-13 1993-02-09 Sanofi Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units
JPH01502909A (ja) * 1987-02-24 1989-10-05 ゾーマ・コーポレーション 免疫毒素による人間の治療における免疫抑制
US4946675A (en) * 1987-05-27 1990-08-07 Xoma Corporation Hepatic blocking agents
GB8809616D0 (en) * 1988-04-22 1988-05-25 Cancer Res Campaign Tech Further improvements relating to drug delivery systems
US5632990A (en) * 1988-04-22 1997-05-27 Cancer Research Campaign Tech. Ltd. Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
US5112607A (en) * 1991-06-05 1992-05-12 The United States Of America As Represented By The Secretary Of The Army Potentiation of immunotoxin action by Brefeldin A
FR2802536B1 (fr) * 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
CN101184780B (zh) 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
JP6096111B2 (ja) * 2010-05-10 2017-03-15 アセンド・バイオファーマシューティカルズ・リミテッド 免疫刺激組成物及びワクチン組成物
US20120177567A1 (en) * 2010-08-11 2012-07-12 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504010B1 (fr) * 1981-04-15 1985-10-25 Sanofi Sa Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
FR2516794B1 (fr) * 1981-11-20 1985-10-25 Sanofi Sa Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
FR2521010B1 (fr) * 1982-02-09 1985-07-19 Sanofi Sa Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent
FR2522968B1 (fr) * 1982-03-10 1986-03-28 Sanofi Sa Medicament cytotoxique forme de l'association d'a u moins une immunotoxine et de la chloroquine
FR2536997B1 (fr) * 1982-03-11 1987-08-07 Sanofi Sa Medicaments cytotoxiques comportant au moins une immunotoxine et de la methylamine
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
FR2577135B1 (fr) * 1985-02-13 1989-12-15 Sanofi Sa Immunotoxines a longue duree d'action comportant un constituant glycopeptidique inactivant les ribosomes modifie sur ses motifs polysaccharidiques

Also Published As

Publication number Publication date
IL77168A0 (en) 1986-04-29
JPS61197528A (ja) 1986-09-01
JPH062679B2 (ja) 1994-01-12
FR2573656A1 (fr) 1986-05-30
IE58776B1 (en) 1993-11-17
US4749566A (en) 1988-06-07
ZA859120B (en) 1986-08-27
EP0186551A1 (fr) 1986-07-02
AU5047385A (en) 1986-06-05
DK163030B (da) 1992-01-13
CA1254139A (en) 1989-05-16
EP0186551B1 (fr) 1990-01-24
DE3575521D1 (de) 1990-03-01
IE852992L (en) 1986-05-29
NZ214357A (en) 1990-02-26
FR2573656B1 (fr) 1987-02-27
ATE49708T1 (de) 1990-02-15
AU588008B2 (en) 1989-09-07
DK554585A (da) 1986-05-30
DK554585D0 (da) 1985-11-29

Similar Documents

Publication Publication Date Title
EG20380A (en) Enhanced skin penetration system for improved topical delivery of drugs
DZ2634A1 (fr) Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FI941771A0 (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
DZ2300A1 (fr) Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
UA32543C2 (uk) Арилацетаміди, що мають анальгетичну дію, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
ZA859120B (en) Drug comprising an association of at least one immunotoxin and at least one mennose-containing polymer
GR3000750T3 (en) Anti-inflammatory agents
FR2705095B1 (fr) Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
FR2712289B1 (fr) Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
ATE263179T1 (de) Kohlenhydrate derivate und die enthaltende zusammensetzungen
FR2658516B1 (fr) Nouveaux produits sterouides comportant un radical spiro en position 17, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2536997B1 (fr) Medicaments cytotoxiques comportant au moins une immunotoxine et de la methylamine
DK591685D0 (da) N-substituerede aziridin-2-carboxylsyrederivater, fremgangsmaade til fremstilling deraf samt laegemidler, der indeholder disse stoffer
FR2694292B1 (fr) Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.
SE8105500L (sv) Psykotropa lekemedel
ES2082260T3 (es) Composiciones inyectables que contienen derivados del 2-oxindol-1-carboxamida.
GB1101458A (en) Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs
IT1189226B (it) Medicamenti e prodotti derivati da 3-idrossidodecaidro benz(e) inden-7-one bisostituiti in posizione 6,procedimento di preparazione e intermedi ottenuti
FR2696174B1 (fr) Nouveaux dérivés chroméniques à chaîne triénique diméthylée, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
MX9203581A (es) Composiciones farmaceuticas de indolinas 3,3-disubstituidas, para administracion nasal.
MA18429A1 (fr) Nouveaux derives de 2-imine-imidazolidine, leur preparation et leur application en tant que medicaments
IL134600A0 (en) Intermediates for naphthyl and dihydronaphthyl compounds, pharmaceutical compositions containing them and uses thereof as medicaments in the treatment of post-menopausal syndrome

Legal Events

Date Code Title Description
PBP Patent lapsed